Professional

Global R&D Collaborations

ON SEPTEMBER 9, 2015
COOPERATED WITH PENN WHARTON CHINA CENTRE TO PREPARE AND ORGANIZE THE HEALTHCARE FORUM

VISIT USA FOR BUSINESS COOPERATION WITH MD ANDERSON CANCER CENTRE

In September, 2016, Mr. Dai Yumin, Chairman of Board of Supervisors of CRMI had a conference with Dr. DePinho, Director of MD Anderson Cancer Centre.

VISIT USA FOR BUSINESS COOPERATION WITH THE MOUNT SINAI HOSPITAL, NEW YORK

In September, 2016, Mr. Dai Yumin, Chairman of Board of Supervisors of CRMI had a conference with Dr. Arthur A. Klein, Director of Mount Sinai Hospital, New York.

CHINA—ETHIOPIA PRODUCTION CAPACITY COOPERATION

In September 2015, Group Chief Executive Officer Mr. Shao Zhengkang participated in "China—Ethiopia Production Capacity Cooperation" held in Beijing and conducted the exchange and discussion on introducing the company’s product "Acornea" to enter Africa.

In 2014, CRMI collaborated with the University of Oxford to establish the technology and R&D centre, bringing the R&D strength of the group to a brand new stage. Following the Rolls-Royce Group and Invensys Group, CRMI is the third enterprise to set up a technology and R & D centre with the University of Oxford.

IR Contact

China Regenerative Medicine International Limited

A:

10/F, Dah Sing Financial Center, 108 Gloucester Road, Wan chai, Hong Kong

E: info@crmi.hk|

T: +852 3966 8388 |

F: +852 2802 0026